Related Experiment Video
Updated: Jan 18, 2026

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
Integrating Cell Population Data With Hematology Analyzer Messages for Improved Detection of Immature White Blood
Lin-Chen Hsu1, Tsung-Han Tsai1, Yu-Hua Lin1
1Department of Laboratory Medicine, An Nan Hospital, China Medical University, Tainan, Taiwan.
Background:
Improving efficiency and reducing turnaround time are crucial in clinical laboratories. While automated analyzers such as the Beckman Coulter DxH 900 streamline workflow, subtle abnormalities like blasts and immature granulocytes (IGs) may be missed, especially in the absence of WBC-related suspect messages. This study evaluated whether integrating cell population data (CPD) with instrument messages could enhance detection accuracy.
Methods:
A total of 587 blood samples were analyzed and classified with (Group A) or without (Group N) WBC-related suspect messages. Manual slide review (MSR) and digital morphology (DM) served as reference standards. CPD parameters were evaluated using receiver operating characteristic (ROC) analysis and Youden's index to establish optimal detection rules.
Results:
Among the 587 samples, 55.3% were in Group A and 44.7% in Group N, with Group A showing significantly lower red blood cell, hemoglobin, and platelet counts (p < 0.001). The DxH 900 flagged 37.7% and 55.4% of samples with blast- and IG-related messages, respectively. However, it failed to detect blasts in 20.6% of cases confirmed by MSR and 21.3% by DM, and missed IGs in 16.2% of MSR-confirmed and 18.7% of DM-confirmed positive samples. CPD parameters (e.g., SD_V_NE, MN_V_NE) identified additional true positives, with area under the curve (AUC) values > 0.9. Integrating CPD rules with WBC-related suspect messages improved sensitivity/specificity to 91.9%/99.0% for blasts and 91.5%/96.7% for IGs, using MSR as the reference standard.
Conclusions:
Integrating CPD parameters with WBC-related suspect messages provides a sensitive, automated secondary screening strategy that reduces false negatives and enhances hematologic diagnostics.
More Related Videos
14:45Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Published on: September 16, 2012
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018